Adherence to varenicline in the COMPASS smoking cessation intervention trial. - Wikidata - wikimedia - TriplyDB

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

http://www.wikidata.org/entity/Q34859460

about

Nicotine receptor partial agonists for smoking cessation Combined pharmacotherapy and behavioural interventions for smoking cessation Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation Nicotine receptor partial agonists for smoking cessation Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder.Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics Early quit days among methadone-maintained smokers in a smoking cessation trial Unannounced telephone pill counts for assessing varenicline adherence in a pilot clinical trial.Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers.Correlates of Adherence to Varenicline Among HIV+ Smokers.Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report.Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment.Comparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment.Integrating tobacco treatment into thoracic oncology settings: Lessons learned.Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers.Evaluating an Adaptive and Interactive mHealth Smoking Cessation and Medication Adherence Program: A Randomized Pilot Feasibility Study.Factors associated with discontinuation of bupropion and counseling among African American light smokers in a randomized clinical trial.Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers.Interventions for tobacco smoking.A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success.A Retrospective Analysis of the Outcomes of Smoking Cessation Pharmacotherapy Among Persons With Mental Health and Substance Use Disorders.The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.Measures and predictors of varenicline adherence in the treatment of nicotine dependence.Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation: a randomized pragmatic trial in primary care.Higher Adherence During Reimbursement of Pharmacological Smoking Cessation Treatments.Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial.Addressing varenicline adherence through repackaging in a dose administration aid.Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo.Adherence to pharmacological smoking cessation interventions: A literature review and synthesis of correlates and barriers.Cancer-related disease factors and smoking cessation treatment: Analysis of an ongoing clinical trial.Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration.

P2860

Q24185773-D60EB705-9544-427F-AA23-E35126DCD038 Q24186008-910F9829-51FF-464B-B525-1CF2D26D6650 Q24186545-0454695D-0213-4653-B0D9-178A433DAAD9 Q24200322-A9A4F295-94A7-45A0-BAB6-E6B246889A0B Q24202466-9AA4FA28-E599-42D4-8A61-14FF521C8624 Q26751374-380B02C1-AB40-494A-969D-A89680CB6AD8 Q33451758-4247E92F-B3D5-4D53-990B-E0D6EF8D7605 Q33854297-4F05FA71-05C5-42F0-8B9D-B8ECE6578F0D Q34736698-ACD49025-6C64-4B06-91C2-D094B846882C Q35327985-D7ED1FAC-5C54-4F19-8E93-6314F5045B10 Q35988550-9E19C8EE-7437-4107-ACF5-34DA7DA180C7 Q36087171-AD235577-D62B-4CCD-92F0-69E9FA07332A Q36203756-6108FA89-0309-488E-8F4E-D964607C3F9D Q36283095-7D120F09-1422-4D87-80E9-DA01CF9CD58C Q36407461-76E4D588-2084-4ADF-98A3-834B8A09DF9D Q36535763-59EA0849-90E8-4AC6-96CA-D2D5B4F011B6 Q36727844-A39D0606-F905-4949-BF59-B97BA4E4B8D6 Q36727868-A1CCC0EF-58BF-4468-A0A7-9ECBF70E7570 Q36777034-498616CC-C1E7-4C54-9605-2BCD9D7673EA Q37145902-67BA4BD2-B669-41F2-A924-EB58B7DC1965 Q37145955-3B869BC1-8C9C-446B-9DE6-83A3A62E5BBF Q37184722-3017D61D-7C2D-457F-908A-BF63AF4342D4 Q37273823-ADF76E40-1BF8-4F95-B3B1-383F2EC9334F Q37282141-F2CBA166-F502-41A0-9A51-34CD88900EE1 Q37395553-969BFBDA-752E-4223-AE9E-46F0F238646D Q37600952-7E6736B1-5F89-43AA-9A20-9166AC2367D2 Q38072454-5599FCFC-25AD-40EC-918C-80A034F4B18C Q38126950-7FAD7E81-5FBA-41FE-B50D-D980C879CEEC Q38760849-B9BFCD5B-D04E-4B2A-96B0-A2F051D03900 Q38801718-75A1AF17-7769-41AB-9E8A-E1D6903DB396 Q40114814-E6462761-B4AC-455D-9411-713E962374E4 Q40138630-F25C0EB5-3F2D-420E-99B7-5885313BDB52 Q41202699-E097E045-73F3-4CC1-A70C-14FEEC9D4F1B Q46463967-186F4AFB-8044-4D0A-ACDF-4AEAEBBE7479 Q47385078-3A122F86-DACC-4D3D-88EB-5861281D207A Q47707596-CBD3DD50-CA92-4676-BAF1-FB6C6891A72D Q47773172-3988A9ED-96CC-4698-ADDE-3CCADC3F81B0 Q47882474-2668A049-E493-4189-871B-EAC39ECE0BD7 Q48242917-62E4A2E1-1DD7-4D31-A87A-B28ADE9020B8 Q50647796-3DEEAE2D-F6E0-46CB-A76C-0D34FBE279AC

P2860

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

http://www.wikidata.org/entity/Q34859460

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@ast

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@en

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@nl

type

label

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@ast

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@en

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@nl

prefLabel

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@ast

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@en

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

@nl

P1433

Q34859460-5ED20F30-A4C2-412C-942F-F24BAF63B04F

P1476

Q34859460-56197364-F31A-4C01-96BB-E48F51F79830

P2093

Q34859460-3570D658-396D-4355-9D60-81A7FE6FB154

Q34859460-3BB67458-66E6-4E32-9145-C880DD148A92

Q34859460-49125866-1D04-4A77-9225-04B58B31B8FA

Q34859460-56A11207-EACF-47A1-BABC-2A640F311EB1

Q34859460-9533C791-9CF1-4F32-ABAF-6FEA9CA83594

Q34859460-AC5DC468-6E35-4228-9E63-10692AAC7B52

Q34859460-BAD4FAD5-E52B-40E6-B4E7-0CD9C0918917

Q34859460-E2F4E7A8-D5AD-4D7C-8A55-52101C743919

P2860

Q34859460-0B393654-D11B-4176-AAB6-17040DA964B7

Q34859460-13D3D9B8-E9C5-4919-8474-3CE882773113

Q34859460-27928404-9C07-4030-BC2A-A76449DE5CB5

Q34859460-426ABF5E-6AC0-46AD-8D6C-DBEE14B3EE0A

Q34859460-47B66FDC-757B-499E-B6FB-77EB918C1743

Q34859460-4D43664D-EBBE-4190-B7A7-9932BC9A9C0F

Q34859460-50760CB4-F038-44B4-93BE-11DCC03CFFFE

Q34859460-63F7C64E-584A-410D-A809-02D6A4CE2880

Q34859460-7268F47C-9D72-47B7-A0BF-6CD376B2DC07

Q34859460-7830C80D-DD56-4810-97DE-F2AC13BDD2F0

P304

Q34859460-CF18F231-D14D-4DC5-8317-ED7EC2EA427F

P31

Q34859460-2FE39D56-7828-42D2-8FEB-916290AA037D

P356

Q34859460-48C6B070-DF3A-4C8B-A1D8-D7776080E466

P433

Q34859460-EDB22CDD-5AE8-48E7-90C1-3E6C721552DB

P478

Q34859460-AD3ECF68-4F7F-424F-A876-54D9B7D2C510

P50

Q34859460-1D3B6BFE-6C78-45C2-A4C1-76289346FAE7

P577

Q34859460-854EB5BC-11EF-4775-8FE0-F2E67F8B123F

P5875

Q34859460-4788E297-F14E-48C6-A802-B12ECD5B72F9

P698

Q34859460-AE89C19D-D39F-41CD-84D5-1B6C69431B53

P932

Q34859460-848F56B7-A3DB-4F83-84A0-7E9C79EB531C

P356

P1433

Nicotine and Tobacco Research

P1476

Adherence to varenicline in the COMPASS smoking cessation intervention trial

@en

P2093

Gary E Swan

http://www.w3.org/2001/XMLSchema#string

Harold S Javitz

http://www.w3.org/2001/XMLSchema#string

Jennifer B McClure

http://www.w3.org/2001/XMLSchema#string

Lisa M Jack

http://www.w3.org/2001/XMLSchema#string

Mona Deprey

http://www.w3.org/2001/XMLSchema#string

Sheryl L Catz

http://www.w3.org/2001/XMLSchema#string

Susan M Zbikowski

http://www.w3.org/2001/XMLSchema#string

Tim McAfee

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotine receptor partial agonists for smoking cessation

Interventions for enhancing medication adherence

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

Behavioral counseling and varenicline treatment for smoking cessation.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

Patient adherence and medical treatment outcomes: a meta-analysis.

Beliefs and attitudes about bupropion: implications for medication adherence and smoking cessation treatment.

Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit.

Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline

P304

361-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NTR/NTR003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Julie E Richards

P577

2011-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50196096

http://www.w3.org/2001/XMLSchema#string

P698

21350041

http://www.w3.org/2001/XMLSchema#string

P932

3082504

http://www.w3.org/2001/XMLSchema#string